On June 26, Achaogen’s Zemdri (plazomicin) obtained a bittersweet victory: the FDA approved its use in complicated urinary tract infections (cUTI...
In DRG Blog/ June, 20182 search results for: biopharma-insights
If you didn't find what you were looking for, try again!